primpol Antibody

What is PrimPol and why is it important in DNA replication research?

PrimPol (also known as CCDC111/FLJ33167) is a specialized enzyme that combines both DNA primase and polymerase activities. It plays a crucial role in maintaining genomic stability by promoting accurate DNA replication and repair mechanisms . PrimPol is particularly important because it can reprime DNA synthesis when replication is arrested by template impediments, allowing replication to restart downstream of DNA lesions .

The significance of PrimPol in research stems from its ability to:

• Initiate de novo DNA synthesis using dNTPs

• Act as an error-prone DNA polymerase capable of bypassing certain DNA lesions

• Facilitate both mitochondrial and nuclear replication fork progression

• Maintain efficient nuclear and mitochondrial DNA replication in unperturbed cells

Dysregulation of PrimPol activity has been linked to various diseases, including cancer and genetic disorders, making it an important target for both fundamental research and therapeutic development .

What applications can PrimPol antibodies be used for in cellular research?

PrimPol antibodies have been validated for multiple experimental applications in cellular research:

For immunofluorescence studies, PrimPol antibodies have been successfully used to track recruitment of PrimPol to specific nuclear regions following DNA damage. For example, researchers have demonstrated PrimPol recruitment to laser-induced DNA damage paths where ICLs (interstrand crosslinks) were created with trimethyl-psoralen and UVA irradiation .

PrimPol antibodies have also been effectively used in chromatin fractionation assays to demonstrate that PrimPol is recruited to chromatin in response to DNA-damaging agents like MMC and TMP-UVA .

How can I validate the specificity of PrimPol antibodies in my experimental system?

To ensure the specificity of PrimPol antibodies, implement these methodological controls:

• Use of PrimPol knockout cells: The most rigorous control is to test the antibody in PrimPol CRISPR/Cas9 knockout cell lines. As demonstrated in multiple studies, no signal should be detected in these cells if the antibody is specific .

• Phosphatase treatment: For phospho-specific PrimPol antibodies (e.g., pS255), treat lysates with lambda phosphatase to verify that antibody recognition is abolished, confirming phospho-specificity .

• Mutant protein controls: For antibodies targeting specific domains or modifications, test recognition using mutant variants. For example, when using antibodies against phosphorylated S255, compare detection between wild-type PrimPol and the S255A mutant .

• Complementation experiments: In PrimPol KO cells, reintroduce exogenous PrimPol and confirm restoration of antibody signal to validate specificity .

• Cross-reactivity testing: When working with novel cell lines, verify the antibody doesn't cross-react with other primases or polymerases by comparing immunoprecipitation results with mass spectrometry data .

What are the optimal fixation and permeabilization methods for PrimPol immunofluorescence studies?

For successful PrimPol immunofluorescence staining, protocol optimization is critical:

• Fixation: Paraformaldehyde (4%) has been effectively used in multiple studies. This preserves protein structure while maintaining epitope accessibility for PrimPol antibodies .

• Permeabilization: 0.25% Triton X-100 in PBS has been validated for PrimPol antibody studies, providing sufficient permeabilization without compromising epitope integrity .

• Blocking conditions: BSA (1-3%) in PBS for 1 hour at room temperature effectively reduces background signal.

• Antibody dilutions: For immunofluorescence, most PrimPol antibodies perform optimally at dilutions between 1:50-1:200, but this should be empirically determined for each antibody .

• Detection systems: For mouse monoclonal PrimPol antibodies, secondary detection using Alexa Fluor 488-conjugated AffiniPure Goat Anti-Mouse IgG has shown good results .

For co-localization studies involving PrimPol and other DNA repair factors (like γH2AX following laser microirradiation), sequential staining may be necessary to avoid cross-reactivity between antibodies .

How can PrimPol antibodies be used to study its role in DNA interstrand crosslink (ICL) repair?

PrimPol antibodies have proven valuable for elucidating its function in ICL repair through several advanced approaches:

• Chromatin fractionation assays: PrimPol antibodies can detect the recruitment of PrimPol to chromatin after treatment with ICL-inducing agents like mitomycin C (MMC) or UVA-activated trimethyl-psoralen (TMP-UVA). This recruitment coincides with FANCD2 ubiquitylation, a marker of ICL repair .

• Co-immunoprecipitation studies: Using PrimPol antibodies for immunoprecipitation followed by mass spectrometry (IP-MS) reveals dynamic interactions between PrimPol and ICL recognition/repair factors, including:

  • MHF1 (part of the FANCM complex)

  • BLM, RMI1, RMI2, and TOP3A (components of the BTR complex)

  • RUNX1
    These interactions are altered upon treatment with ICL-inducing agents .

• Laser microirradiation: PrimPol antibodies can track recruitment of PrimPol to defined areas of ICL damage created by UVA laser paths in TMP-treated cells. This provides spatial and temporal analysis of PrimPol function during ICL repair .

• PRIMPOL knockout validation: PrimPol antibodies confirm the absence of PrimPol in CRISPR/Cas9 PRIMPOL knockout cells used for functional studies of ICL repair pathways, demonstrating that PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks .

What controls are needed when studying PrimPol phosphorylation in response to replication stress?

When investigating PrimPol phosphorylation in response to replication stress, implement these critical controls:

• Phospho-specific antibody validation:

  • Compare detection between wild-type and phospho-mutant (e.g., S255A) PrimPol to confirm specificity

  • Treat samples with lambda phosphatase to abolish antibody recognition

  • For newly developed phospho-specific antibodies, validate using mass spectrometry

• Kinase inhibitor controls:

  • Include CHK1 inhibitors (e.g., VX-970 at 1μM) to confirm CHK1-dependent phosphorylation

  • ATR inhibitors should also be included since ATR operates upstream of CHK1 in the replication stress response

• Mass spectrometry validation:

  • SILAC-IP-MS (stable isotope labeling of amino acids in cell culture with immunoprecipitation followed by mass spectrometry) can quantitatively confirm phosphorylation sites

  • Compare phosphopeptide abundance between normal and CHK1-inhibited conditions

  • Extract ion chromatograms should be generated using calculated m/z values with appropriate ppm tolerance

• Replication stress inducers:

  • Include distinct replication stress inducers like POLα inhibitor (CD437), hydroxyurea, or cisplatin to determine stress-specific phosphorylation responses

  • Compare phosphorylation levels under different types of replication stress

How can I use PrimPol antibodies to study the integration of PrimPol-mediated repriming with other DNA damage tolerance pathways?

To investigate how PrimPol-mediated repriming integrates with other DNA damage tolerance pathways:

• Protein interaction studies:

  • Use PrimPol antibodies for co-immunoprecipitation to identify interactions with:

    • REV1 and other Y-family polymerases involved in on-the-fly lesion bypass

    • PCNA and its modified forms (ubiquitinated, SUMOylated)

    • Homologous recombination factors that process repriming-generated gaps

• Chromatin association dynamics:

  • Perform chromatin fractionation followed by immunoblotting with PrimPol antibodies in cells deficient for:

    • Fork reversal factors (SMARCAL1, HLTF, ZRANB3)

    • Translesion synthesis polymerases (POLη, REV1)

    • PCNA modification (PCNA K164R mutant cells)
      This reveals how impairment of alternative damage tolerance pathways affects PrimPol recruitment

• S1 nuclease-modified DNA combing:

  • This specialized technique incorporates S1 nuclease digestion with DNA combing to detect single-stranded DNA gaps

  • PrimPol activity creates S1-sensitive regions due to leading strand ssDNA gaps

  • PrimPol antibodies can confirm the presence of PrimPol at these sites through chromatin immunoprecipitation followed by sequencing (ChIP-seq)

• Genetic interaction studies:

  • Use PrimPol antibodies to confirm protein depletion or knockout in sensitivity assays

  • Combine PrimPol deficiency with defects in other damage tolerance pathways (REV1, POLη, PCNA K164) to understand genetic relationships

  • These studies have revealed that "PRIMPOL is required to maximise the effectiveness of the interaction between" on-the-fly translesion synthesis and post-replicative gap filling

How can PrimPol antibodies be used to study its role in cancer-associated mutations?

PrimPol antibodies enable detailed investigation of cancer-associated PrimPol mutations through several approaches:

• Structural-functional analysis:

  • Cancer-associated point mutations like Y100H (which disables the steric gate of PrimPol) can be studied by comparing wild-type and mutant protein levels and localization using PrimPol antibodies

  • This mutation affects discrimination between ribonucleotides and deoxyribonucleotides, which can be analyzed through immunoprecipitation of PrimPol followed by activity assays

• Expression profiling in cancer tissues:

  • Immunohistochemistry using PrimPol antibodies can assess expression levels and cellular localization in cancer vs. normal tissues

  • PrimPol antibodies have been validated for use in paraffin-embedded human tissues, including colonic and placental samples, making them suitable for clinical specimen analysis

• Response to chemotherapeutic agents:

  • PrimPol's role in responding to cisplatin (a common chemotherapeutic) can be studied using PrimPol antibodies

  • For example, chemotherapy-induced upregulation of PrimPol has been observed using PrimPol antibodies in immunoblotting of chromatin fractions

  • In BRCA1/2-deficient cancer cells, PrimPol recruitment to chromatin correlates with resistance to fork degradation induced by cisplatin, as detected by PrimPol antibodies

• Genetic compensation mechanisms:

  • In cancer cells with defects in canonical DNA repair pathways, PrimPol may be upregulated as a compensation mechanism

  • PrimPol antibodies can track these changes through western blotting and immunofluorescence to identify potential therapeutic vulnerabilities

What are the recommended protocols for detecting PrimPol in different cellular compartments?

Since PrimPol functions in both nuclear and mitochondrial DNA replication, specialized protocols are needed for accurate compartmental detection:

• Nuclear PrimPol detection:

  • Chromatin fractionation: Isolate chromatin-bound PrimPol using CSK buffer (10 mM PIPES pH 7, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl₂) with 0.5% Triton X-100

  • Immunofluorescence: For nuclear PrimPol, pre-extraction with 0.5% Triton X-100 before fixation improves detection of chromatin-bound fraction

  • Co-staining: Combine PrimPol antibodies with nuclear markers (DAPI) and replication fork markers (PCNA, RPA) to visualize PrimPol at active replication sites

• Mitochondrial PrimPol detection:

  • Mitochondrial isolation: Differential centrifugation followed by immunoblotting with PrimPol antibodies

  • Immunofluorescence: Co-stain with mitochondrial markers (MitoTracker or TOM20 antibodies) and use confocal microscopy to confirm mitochondrial localization

  • Super-resolution microscopy: For precise localization, techniques like STORM or STED microscopy provide enhanced resolution of mitochondrial PrimPol

• Distinguishing populations:

  • Biochemical approach: Sequential extraction methods that differentially extract soluble nucleoplasmic, chromatin-bound, and mitochondrial fractions

  • Protease protection assay: Mitochondrial preparations treated with proteinase K will lose outer membrane proteins while protecting matrix proteins like mitochondrial PrimPol

  • Immunoelectron microscopy: For definitive localization, immuno-gold labeling with PrimPol antibodies provides ultrastructural evidence of compartment-specific localization

What are common issues when detecting phosphorylated forms of PrimPol and how can they be addressed?

Detection of phosphorylated PrimPol presents several challenges that can be methodically addressed:

• Low abundance issues:

  • Problem: Phosphorylated PrimPol often exists at low levels, even under stress conditions

  • Solution: Enrich phosphorylated proteins using titanium dioxide (TiO₂) or phospho-enrichment columns before immunoblotting

  • Alternative: Use SILAC-IP-MS methods which can detect phosphopeptides at very low abundance levels

• Phosphatase activity during lysis:

  • Problem: Rapid dephosphorylation during sample preparation

  • Solution: Include multiple phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate, and commercial cocktails like PhoSTOP) in all buffers

  • Critical step: Maintain samples at 4°C throughout processing and avoid repeated freeze-thaw cycles

• Phospho-specific antibody validation:

  • Problem: Non-specific recognition of similar phospho-motifs

  • Solution: Always include phosphatase-treated controls and phospho-mutant proteins (e.g., S255A mutant) as negative controls

  • Additional control: Compete binding with excess phosphopeptide to confirm specificity

• Detection of specific phosphorylation sites:

  • Problem: Multiple phosphorylation events may occur simultaneously

  • Solution: Use site-specific phospho-antibodies (like the PrimPol pS255 antibody) in combination with mass spectrometry

  • Approach: Analyze phosphorylation kinetics using targeted parallel reaction monitoring (PRM) mass spectrometry

How can I optimize immunoprecipitation protocols for studying PrimPol protein interactions?

For successful immunoprecipitation of PrimPol and its interaction partners:

• Optimizing lysis conditions:

  • Use mild lysis buffers containing 150-300 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.5% NP-40 or 0.5% Triton X-100

  • Include protease inhibitor cocktails and phosphatase inhibitors if phosphorylation status is important

  • For nuclear interactions, include nuclease treatment (e.g., benzonase) to release chromatin-bound complexes

• Crosslinking considerations:

  • For transient interactions, consider mild formaldehyde crosslinking (0.1-0.3%) for 10 minutes at room temperature

  • For proximity-based interactions, consider BioID or APEX2 proximity labeling approaches as alternatives to conventional IP

• IP-MS workflow optimization:

  • For identification of novel interaction partners, combine SILAC labeling with IP-MS

  • Compare PrimPol interactomes under different conditions (e.g., untreated vs. MMC-treated cells)

  • Use label-swapping experiments to eliminate contaminants and increase confidence in results

• Validation strategies:

  • Confirm key interactions using reciprocal IPs (e.g., IP PrimPol and detect partner, then IP partner and detect PrimPol)

  • For dynamic interactions like the PrimPol-BTR interaction that is disrupted during cellular response to MMC, carefully time the analysis to capture the relevant cellular state

  • Consider using proximity ligation assay (PLA) to validate interactions in situ, which provides spatial information about where in the cell the interaction occurs

How can DNA fiber analysis be combined with PrimPol antibodies to study its role in replication fork dynamics?

Integrating DNA fiber analysis with PrimPol antibody techniques provides powerful insights into replication dynamics:

• Modified DNA combing with immunodetection:

  • Label replicating DNA with nucleoside analogs (CldU/IdU)

  • Perform DNA combing and detect labeled tracks

  • Follow with in situ immunodetection using PrimPol antibodies

  • This approach allows direct visualization of PrimPol at specific replication structures

• S1 nuclease-modified fiber analysis:

  • This specialized technique detects ssDNA gaps generated by repriming

  • When PrimPol is active, elongating DNA fibers become sensitive to S1 nuclease

  • This S1 sensitivity indicates PrimPol-generated leading strand gaps

  • Compare fibers from wild-type and PRIMPOL knockout cells to confirm PrimPol-specific effects

• Triple-label fiber analysis for ICL traverse:

  • This approach identifies three main types of replication tracks around ICLs:
    i. Single forks stalled at ICLs
    ii. Two forks converging at ICLs
    iii. Single forks that have traversed the lesion

  • PrimPol knockout cells show drastically reduced traverse reactions (26% compared to 60% in wild-type cells)

  • This effect can be rescued by reintroducing wild-type PrimPol but not catalytic mutants (AxA) or primase-deficient versions (ΔZn)

• Fork protection analysis in BRCA-deficient cells:

  • PrimPol antibodies confirm PrimPol upregulation following cisplatin pre-treatment

  • DNA fiber analysis shows that this upregulation correlates with protection of nascent DNA from degradation

  • PrimPol depletion (confirmed by antibodies) restores fork degradation to control levels

What are the current methodological approaches for studying PrimPol's dual primase and polymerase activities in cells?

Investigating PrimPol's dual enzymatic activities in cellular contexts requires sophisticated methodological approaches:

• Structure-function studies with mutant complementation:

  • Generate cell lines expressing PrimPol variants with specific defects:

    • AxA mutant (catalytically inactive)

    • ΔZn or C419G/H426Y mutants (primase-deficient but polymerase-active)

    • Y100H mutant (altered nucleotide discrimination)

  • Validate expression levels using PrimPol antibodies

  • Measure functional outcomes (replication speed, cell survival) to determine which activity is required in specific contexts

• Proximity-based labeling to identify activity-specific partners:

  • Fuse BioID or APEX2 to wild-type or activity-specific mutants of PrimPol

  • Identify differential interactomes to distinguish primase-specific vs. polymerase-specific partners

  • Validate findings with PrimPol antibodies in co-IP experiments

• In vivo nascent DNA capture:

  • Use EdU labeling followed by click chemistry to isolate newly synthesized DNA

  • Analyze the 5' ends of nascent DNA by high-throughput sequencing

  • Compare wild-type cells to those expressing primase-deficient PrimPol to identify PrimPol-dependent initiation events

• Activity-based sensors:

  • Develop fluorescent reporters that respond specifically to repriming events

  • Combine with PrimPol immunofluorescence to correlate protein presence with activity

  • Use in live-cell imaging to track repriming dynamics in real-time